Sailer M - Search Results

1

Influence of cerebral lesion volume and lesion distribution on event-related brain potentials in multiple sclerosis.

Sailer M, Heinze HJ, Tendolkar I, Decker U, Kreye O, v Rolbicki U, Münte TF. Sailer M, et al. J Neurol. 2001 Dec;248(12):1049-55. doi: 10.1007/s004150170024. J Neurol. 2001. PMID: 12013581 Clinical Trial.

2

Focal thinning of the cerebral cortex in multiple sclerosis.

Sailer M, Fischl B, Salat D, Tempelmann C, Schönfeld MA, Busa E, Bodammer N, Heinze HJ, Dale A. Sailer M, et al. Brain. 2003 Aug;126(Pt 8):1734-44. doi: 10.1093/brain/awg175. Epub 2003 Jun 4. Brain. 2003. PMID: 12805100

3

Amantadine influences cognitive processing in patients with multiple sclerosis.

Sailer M, Heinze HJ, Schoenfeld MA, Hauser U, Smid HG. Sailer M, et al. Pharmacopsychiatry. 2000 Jan;33(1):28-37. doi: 10.1055/s-2000-7966. Pharmacopsychiatry. 2000. PMID: 10721881 Clinical Trial.

4

Cognitive impairment in primary and secondary progressive multiple sclerosis.

Wachowius U, Talley M, Silver N, Heinze HJ, Sailer M. Wachowius U, et al. Among authors: sailer m. J Clin Exp Neuropsychol. 2005 Jan;27(1):65-77. doi: 10.1080/138033990513645. J Clin Exp Neuropsychol. 2005. PMID: 15814443 Clinical Trial.

5

The effect of coaching on the simulated malingering of memory impairment.

Rüsseler J, Brett A, Klaue U, Sailer M, Münte TF. Rüsseler J, et al. Among authors: sailer m. BMC Neurol. 2008 Oct 7;8:37. doi: 10.1186/1471-2377-8-37. BMC Neurol. 2008. PMID: 18838010 Free PMC article.

6

T1 lesion load and cerebral atrophy as a marker for clinical progression in patients with multiple sclerosis. A prospective 18 months follow-up study.

Sailer M, Losseff NA, Wang L, Gawne-Cain ML, Thompson AJ, Miller DH. Sailer M, et al. Eur J Neurol. 2001 Jan;8(1):37-42. doi: 10.1046/j.1468-1331.2001.00147.x. Eur J Neurol. 2001. PMID: 11509079

7

Effect of creatine supplementation on metabolite levels in ALS motor cortices.

Vielhaber S, Kaufmann J, Kanowski M, Sailer M, Feistner H, Tempelmann C, Elger CE, Heinze HJ, Kunz WS. Vielhaber S, et al. Among authors: sailer m. Exp Neurol. 2001 Dec;172(2):377-82. doi: 10.1006/exnr.2001.7797. Exp Neurol. 2001. PMID: 11716561

8

Histopathology and serial, multimodal magnetic resonance imaging in a multiple sclerosis variant.

Lindquist S, Bodammer N, Kaufmann J, König F, Heinze HJ, Brück W, Sailer M. Lindquist S, et al. Among authors: sailer m. Mult Scler. 2007 May;13(4):471-82. doi: 10.1177/1352458506071329. Epub 2007 Feb 9. Mult Scler. 2007. PMID: 17463070

9

Constraint-induced aphasia therapy following sub-acute stroke: a single-blind, randomised clinical trial of a modified therapy schedule.

Sickert A, Anders LC, Münte TF, Sailer M. Sickert A, et al. Among authors: sailer m. J Neurol Neurosurg Psychiatry. 2014 Jan;85(1):51-5. doi: 10.1136/jnnp-2012-304297. Epub 2013 Jul 4. J Neurol Neurosurg Psychiatry. 2014. PMID: 23828834 Clinical Trial.

10

Defective mitochondrial oxidative phosphorylation in myopathies with tubular aggregates originating from sarcoplasmic reticulum.

Vielhaber S, Schröder R, Winkler K, Weis S, Sailer M, Feistner H, Heinze HJ, Schröder JM, Kunz WS. Vielhaber S, et al. Among authors: sailer m. J Neuropathol Exp Neurol. 2001 Nov;60(11):1032-40. doi: 10.1093/jnen/60.11.1032. J Neuropathol Exp Neurol. 2001. PMID: 11706933

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

258 results

Search Page

Filters